| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-09 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-09 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-09 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |